1482 related articles for article (PubMed ID: 16996901)
1. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
2. Impact of tiotropium on the course of moderate-to-very severe chronic obstructive pulmonary disease: the UPLIFT trial.
Tashkin DP
Expert Rev Respir Med; 2010 Jun; 4(3):279-89. PubMed ID: 20524910
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of chronic obstructive pulmonary disease: review of therapeutic interventions.
Anzueto A
Am J Med; 2006 Oct; 119(10 Suppl 1):46-53. PubMed ID: 16996899
[TBL] [Abstract][Full Text] [Related]
4. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
Kurashima K; Hara K; Yoneda K; Kanauchi T; Kagiyama N; Tokunaga D; Takayanagi N; Ubukata M; Sugita Y
Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
[TBL] [Abstract][Full Text] [Related]
5. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
Hanania NA
Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
[TBL] [Abstract][Full Text] [Related]
6. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology.
Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA
COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060
[TBL] [Abstract][Full Text] [Related]
7. TORCH and UPLIFT: what has been learned from the COPD "mega-trials"?
Niewoehner DE
COPD; 2009 Feb; 6(1):1-3. PubMed ID: 19229702
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
9. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
[TBL] [Abstract][Full Text] [Related]
10. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
Gordon E; Lazarus SC
J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
[TBL] [Abstract][Full Text] [Related]
11. [The UPLIFT study: future perspectives].
Rodríguez González-Moro JM; Lucero S; de Lucas Ramos P
Arch Bronconeumol; 2008; 44 Suppl 2():39-48. PubMed ID: 19087842
[TBL] [Abstract][Full Text] [Related]
12. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
Heijdra YF
Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
[TBL] [Abstract][Full Text] [Related]
13. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
Koumis T; Samuel S
Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
15. Innovations to achieve excellence in COPD diagnosis and treatment in primary care.
Fromer L; Barnes T; Garvey C; Ortiz G; Saver DF; Yawn B
Postgrad Med; 2010 Sep; 122(5):150-64. PubMed ID: 20861599
[TBL] [Abstract][Full Text] [Related]
16. Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y; Tateishi Y; Umeda N; Yoshikawa T; Kamoi H; Kanazawa H; Kudoh S; Hirata K; Fujimoto S
Osaka City Med J; 2007 Jun; 53(1):25-34. PubMed ID: 17867631
[TBL] [Abstract][Full Text] [Related]
17. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
18. Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study.
Jung KS; Park HY; Park SY; Kim SK; Kim YK; Shim JJ; Moon HS; Lee KH; Yoo JH; Lee SD; ;
Respir Med; 2012 Mar; 106(3):382-9. PubMed ID: 21975275
[TBL] [Abstract][Full Text] [Related]
19. Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD.
Hanania NA; Crater GD; Morris AN; Emmett AH; O'Dell DM; Niewoehner DE
Respir Med; 2012 Jan; 106(1):91-101. PubMed ID: 22040533
[TBL] [Abstract][Full Text] [Related]
20. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
